PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO

PROCEPT BioRobotics Corp

2025-Q2 EPS reported -$0.80 revenue$148,344,000

Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).
Net loss improved to $19.6M from $25.6M; Adjusted EBITDA loss $8.0M (vs. $17.9M loss prior year).
Gross margin expanded to 65% from 59% due to operational efficiencies and higher system ASP.
Raises FY 2025 revenue guidance to $325.5M (45% growth) from prior $323.0M; expects 64.5% gross margin.
Appoints Larry Wood as CEO effective Sept. 2, 2025; brings 40 years medtech leadership.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.